November 1, 2017 / 9:41 PM / 2 months ago

BRIEF-Mirati Therapeutics reports Q3 loss per share of $0.65

Nov 1 (Reuters) - Mirati Therapeutics Inc

* Mirati Therapeutics reports third quarter 2017 financial results

* Q3 loss per share $0.65

* Q3 earnings per share view $-0.82 -- Thomson Reuters I/B/E/S

* ‍Research and development expenses for Q3 of 2017 were $13.5 million, compared to $16.1 million for same period in 2016​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below